SHELDON KAPLAN to Vancomycin
This is a "connection" page, showing publications SHELDON KAPLAN has written about Vancomycin.
Connection Strength
1.414
-
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
Score: 0.273
-
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
Score: 0.183
-
In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis. 1998 May; 26(5):1169-76.
Score: 0.127
-
Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2018 05; 62(5).
Score: 0.127
-
Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci. Pediatr Neurosurg. 2018; 53(4):243-246.
Score: 0.127
-
The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. Pediatr Infect Dis J. 2017 06; 36(6):572-577.
Score: 0.119
-
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 1993 Dec; 37(12):2522-6.
Score: 0.094
-
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S172-7.
Score: 0.046
-
Hematologic effects of linezolid in young children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S186-92.
Score: 0.046
-
Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Pediatr Infect Dis J. 2023 06 01; 42(6):449-455.
Score: 0.044
-
Management of pneumococcal meningitis. Pediatr Infect Dis J. 2002 Jun; 21(6):589-91; discussion 613-4.
Score: 0.042
-
Reply to Marx et al. Clin Infect Dis. 2017 10 15; 65(8):1429-1430.
Score: 0.031
-
Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J. 2017 Oct; 36(10):947-951.
Score: 0.031
-
Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
Score: 0.027
-
Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993 Nov; 37(11):2401-6.
Score: 0.023
-
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011 Feb 01; 52(3):285-92.
Score: 0.019
-
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 01; 52(3):e18-55.
Score: 0.019
-
Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatr Infect Dis J. 1990 Feb; 9(2):138-9.
Score: 0.018
-
Vancomycin pharmacokinetics in premature infants. Pediatr Pharmacol (New York). 1985; 5(1):17-22.
Score: 0.013
-
Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics. 1989 Dec; 84(6):977-85.
Score: 0.004